MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0141878
Sapna Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹49.88 Cr
▲ 69% YoY
Net profit · FY 2024
₹12.65 Lakh
Net margin 0.3%
EBITDA · FY 2024
₹57.72 Lakh
EBITDA margin 1.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹13 Cr
Satisfied ₹11.5 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
24
Provident fund records
About Sapna Pharmaceuticals Private Limited
Data last updated:
Sapna Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2011PTC057887. Its GSTIN is 29AAPCS5829R1Z3 (Karnataka).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Susheela Kothari and Mamta Ramesh Kothari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.269/2 Ground Floor Kothari Business Chambers Mysore Road, Bangalore, Karnataka, India – 560026.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.88 Cr, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹12.65 Lakh (net margin 0.3%) and EBITDA of ₹57.72 Lakh (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 5% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Coreband. As per MCA filings, the company has open charges of ₹13 Cr and satisfied charges of ₹11.5 Cr on record. Court records list 14 cases involving the company, including 9 filed by the company and 5 filed against it; 6 cases are pending.
Sapna Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0141878). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website coreband.in.
Company details
CIN U24230KA2011PTC057887
Registration Number 057887
Incorporation Date 28 March 2011
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0141878
Recognitions & Rankings of Sapna Pharmaceuticals
Contact details
Sapna Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is coreband.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.269/2 Ground Floor Kothari Business Chambers Mysore Road, Bangalore, Karnataka, India – 560026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sapna Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sapna Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sapna Pharmaceuticals operates one associated brand: Coreband. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medical products including bandages and surgical tapes supplied in Bangalore. | coreband.in |
Business activity
The main business activity of Sapna Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sapna Pharmaceuticals Private Limited, buy the company report.
Financials of Sapna Pharmaceuticals Private Limited
FY 2024 filings availableSapna Pharmaceuticals Private Limited reported revenue of ₹49.88 Cr (up 69% YoY) for FY 2024.
Revenue · FY 2024
₹49.88 Cr ▲ 69%
Net profit · FY 2024
₹12.65 Lakh margin 0.3%
EBITDA · FY 2024
₹57.72 Lakh margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 69%
3 years · compounded
▲ 23%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 16%
5 years · compounded
▼ 19%
Revenue rose 69% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sapna Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sapna Pharmaceuticals Private Limited
Sapna Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Susheela Kothari | Director | 20 Mar 2023 | 3 Years 7 Months | Current |
| Mamta Ramesh Kothari | Director | 12 Feb 2025 | 1 Years 8 Months | Current |
| Ramesh Kumar Kothari | Director | 12 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Sapna Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viraj Pharmaceuticals Private Limited | ₹50.17 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Hexacare Pharmaceuticals Private Limited | ₹50.05 Cr (FY 2025) | 18.0% | Chennai, Tamil Nadu, India | |||
| Veritas Life Sciences Limited | ₹50.05 Cr (FY 2025) | 45.0% | Narela, Delhi, India | |||
| Dosch Pharmaceuticals Pvt Ltd | ₹49.93 Cr (FY 2019) | 23.0% | Mumbai, Maharashtra, India | |||
| Sapna Pharmaceuticals Private Limitedthis company | ₹49.88 Cr (FY 2024) | ₹12.65 Lakh | 0.3% | 69.0% | 24 | Bangalore, Karnataka, India |
| Venus Pharmagenerics Private Limited | ₹49.76 Cr (FY 2016) | 7.0% | Solan, Himachal Pradesh, India | |||
| Lazerhead Lifesciences Private Limited | ₹49.03 Cr (FY 2024) | 3005.0% | Telangana, India | |||
| Rena Exports Private Limited | ₹49.02 Cr (FY 2024) | 38.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sapna Pharmaceuticals Private Limited, buy the company report.
Auditor
Sapna Pharmaceuticals Private Limited is audited by M N REDDY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M N REDDY & ASSOCIATES | FY 2023 | 007727S |
Shareholding
The shareholding of Sapna Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sapna Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13 Cr
Satisfied charges
₹11.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Oct 2022 | 100620400 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 29 Jul 2011 | 10306631 | Development Credit Bank Limited | ₹3 Cr | Open | |
| 23 Mar 2015 | 10562307 | Yes Bank Limited | ₹6.5 Cr | Satisfied | |
| 09 Feb 2013 | 10406415 | Ing Vysya Bank Limited | ₹5 Cr | Satisfied |
To see the full charge records of Sapna Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Sapna Pharmaceuticals Private Limited has 14 court cases on record: 9 filed by Sapna Pharmaceuticals, 5 filed against it. 6 cases are pending and 8 are disposed.
Total cases
14
Filed by the company
9
Filed against the company
5
Pending
6
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 4 | 6 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Neon Laboraties Limited | Pending |
| District court, Chennai, Tamil Nadu | Criminal complaint | Filed against the company | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Summons For Judgement) | Filed against the company by Neon Laboraties Limited | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against M/S. Life Aura Pharma | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against an individual | Pending |
To see the full case history of Sapna Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sapna Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sapna Pharmaceuticals Private Limited has a workforce of 24 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
Employee growth
20%
GST
Sapna Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAPCS5829R1Z3 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sapna Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sapna Pharmaceuticals Private Limited has 8 board changes on record since 2014: 3 appointments and 5 cessations. The latest: Susheela Kothari ceased to be Director on 14 Feb 2025.
Ceased
Susheela Kothari ceased to be Director.
Appointed
Mamta Ramesh Kothari was appointed as Director.
Appointed
Ramesh Kumar Kothari was appointed as Director.
AGM
Sapna Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sapna Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Ceased
Ramesh Kumar Kothari ceased to be Director.
Appointed
Susheela Kothari was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100620400 was registered on 20 Oct 2022.
Ceased
Dinesh Kothari ceased to be Director.
Charges
A charge registered on 23 Mar 2015 via Charge ID 10562307 with Yes Bank Limited was fully satisfied on 02 Jun 2016.
Ceased
Tinu Kothari ceased to be Additional Director.
Charges
A charge registered on 09 Feb 2013 via Charge ID 10406415 with Ing Vysya Bank Limited was fully satisfied on 17 Apr 2015.
7 earlier events are in the company report.
Frequently asked questions
Sapna Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 March 2011 (15+ years old) and is registered under CIN U24230KA2011PTC057887.
Sapna Pharmaceuticals has 3 current directors:
- Susheela Kothari - Director
- Mamta Ramesh Kothari - Director
- Ramesh Kumar Kothari - Director
The latest financial statements of Sapna Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sapna Pharmaceuticals is 29AAPCS5829R1Z3, registered in Karnataka.
The CIN (Corporate Identification Number) of Sapna Pharmaceuticals is U24230KA2011PTC057887. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sapna Pharmaceuticals has 14 court cases on record: 9 filed by the company and 5 filed against it. 6 are pending. Most are in the district courts.
Sapna Pharmaceuticals was incorporated on 28 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Sapna Pharmaceuticals by revenue are Viraj Pharmaceuticals Private Limited, Hexacare Pharmaceuticals Private Limited, Veritas Life Sciences Limited, Dosch Pharmaceuticals Pvt Ltd, Venus Pharmagenerics Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Susheela Kothari ceased to be Director on 14 Feb 2025. Mamta Ramesh Kothari was appointed as Director on 12 Feb 2025. Ramesh Kumar Kothari was appointed as Director on 12 Feb 2025. Sapna Pharmaceuticals has 8 board changes on record in total.
Yes, Sapna Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0141878).
Sapna Pharmaceuticals can be reached through the website coreband.in. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages